These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36863792)

  • 21. DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity.
    Baca P; Barajas-Olmos F; Mirzaeicheshmeh E; Zerrweck C; Guilbert L; Sánchez EC; Flores-Huacuja M; Villafán R; Martínez-Hernández A; García-Ortiz H; Contreras-Cubas C; Centeno-Cruz F; Orozco L
    Nutr Diabetes; 2022 Dec; 12(1):50. PubMed ID: 36535927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk.
    Dayeh T; Tuomi T; Almgren P; Perfilyev A; Jansson PA; de Mello VD; Pihlajamäki J; Vaag A; Groop L; Nilsson E; Ling C
    Epigenetics; 2016 Jul; 11(7):482-8. PubMed ID: 27148772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.
    Yang BT; Dayeh TA; Volkov PA; Kirkpatrick CL; Malmgren S; Jing X; Renström E; Wollheim CB; Nitert MD; Ling C
    Mol Endocrinol; 2012 Jul; 26(7):1203-12. PubMed ID: 22570331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics in Human Obesity and Type 2 Diabetes.
    Ling C; Rönn T
    Cell Metab; 2019 May; 29(5):1028-1044. PubMed ID: 30982733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic markers to further understand insulin resistance.
    Ling C; Rönn T
    Diabetologia; 2016 Nov; 59(11):2295-2297. PubMed ID: 27650286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic modifications: An important mechanism in diabetic disturbances.
    Rorbach-Dolata A; Kubis A; Piwowar A
    Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):960-974. PubMed ID: 29225202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes.
    Dhawan P; Vasishta S; Balakrishnan A; Joshi MB
    Life Sci; 2022 Jun; 298():120490. PubMed ID: 35331720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.
    Akbari M; Hassan-Zadeh V
    Inflammopharmacology; 2020 Apr; 28(2):345-362. PubMed ID: 31707555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.
    Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R
    Metabolism; 2014 Sep; 63(9):1188-97. PubMed ID: 24996265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.
    Nilsson E; Matte A; Perfilyev A; de Mello VD; Käkelä P; Pihlajamäki J; Ling C
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1491-501. PubMed ID: 26418287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity.
    Rautenberg EK; Hamzaoui Y; Coletta DK
    Front Endocrinol (Lausanne); 2022; 13():968268. PubMed ID: 36093112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic and epigenetic basis of type 2 diabetes and obesity.
    Drong AW; Lindgren CM; McCarthy MI
    Clin Pharmacol Ther; 2012 Dec; 92(6):707-15. PubMed ID: 23047653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications.
    Schrader S; Perfilyev A; Ahlqvist E; Groop L; Vaag A; Martinell M; García-Calzón S; Ling C
    Diabetes Care; 2022 Jul; 45(7):1621-1630. PubMed ID: 35607770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation in the pathogenesis of polycystic ovary syndrome.
    Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
    Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetics of methylation modifications in diabetic cardiomyopathy.
    Hao J; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics and Type 2 Diabetes Risk.
    Dhawan S; Natarajan R
    Curr Diab Rep; 2019 Jun; 19(8):47. PubMed ID: 31250127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion.
    Dayeh T; Volkov P; Salö S; Hall E; Nilsson E; Olsson AH; Kirkpatrick CL; Wollheim CB; Eliasson L; Rönn T; Bacos K; Ling C
    PLoS Genet; 2014 Mar; 10(3):e1004160. PubMed ID: 24603685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients.
    Volkmar M; Dedeurwaerder S; Cunha DA; Ndlovu MN; Defrance M; Deplus R; Calonne E; Volkmar U; Igoillo-Esteve M; Naamane N; Del Guerra S; Masini M; Bugliani M; Marchetti P; Cnop M; Eizirik DL; Fuks F
    EMBO J; 2012 Mar; 31(6):1405-26. PubMed ID: 22293752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics in β-cell adaptation and type 2 diabetes.
    Kim H; Kulkarni RN
    Curr Opin Pharmacol; 2020 Dec; 55():125-131. PubMed ID: 33232934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.